In Australia, the two Bills related to the proposed establishment of the A$20 billion ($15.3 billion) Medical Research Future Fund (MRFF) have been referred to the Senate’s Community Affairs Legislation Committee for a swift inquiry, with comment invited by July 10.
The Senate committee is due to report back to the Senate on August 10. Once fully established, the MRFF is expected to add around A$1 billion per year to existing government spend for health and medical research and innovation.
During debate on the Bill, the Opposition expressed concern over the proposed administration of MRFF disbursements, and the lack of any formal independent mechanism or peer-reviewed oversight of the distributions of funds, according to a report by the trade group AusBiotech.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze